Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
NM32 is a first-in-class half-life-enhanced T-cell engager targeting ROR1, a tumor associated antigen with broad expression in solid tumors and hematological malignancies Low molecular...
-
19. April 2022 19:36 ET | Quelle: Barrow Neurological Institute at Dignity Health St. Joseph's Hospital and Medical Center
PHOENIX, April 19, 2022 (GLOBE NEWSWIRE) -- Barrow Neurological Institute has officially opened a new neuroscience facility that is expected to serve as a national model for enhancing the patient...
-
London, March 18, 2020 (GLOBE NEWSWIRE) -- Collagen has a wide range of applications due to its properties such as low viscosity in aqueous solutions, neutral odor, colorlessness, transparency,...
-
London, Oct. 16, 2019 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Nutraceutical Ingredients Market by Product Type (Vitamins, Amino Acids, Probiotic, Minerals), Derivation...
-
DALLAS, TX--(Marketwired - Nov 11, 2013) - Harry Wang, Director, Health & Mobile Product Research, Parks Associates, is moderating the session "mHealth: Pushing the Needle Forward in...